Enter assignee name

Trademarks = 1

Forward Citations = 16

Loading Chart...

6 inventors (with patents filed for the assignee):

Nicholas D Smith (8 out of 57 patents)

Steven P Govek (7 out of 34 patents)

Johnny Yasuo Nagasawa (6 out of 27 patents)

4. Karensa L Douglas (2 out of 6 patents)

5. Andiliy Gokching Lai (2 out of 19 patents)

6. Stephen P Govek (1 out of 1 patent)

8 patents: Sort by Forward Citations

1. 11236071 - Farnesoid X receptor agonists and uses thereof (2022-02-01),

2. 11214538 - Farnesoid X receptor agonists and uses thereof (2022-01-04),

3. 11084817 - Farnesoid X receptor agonists and uses thereof (2021-08-10),

4. 10961198 - Farnesoid X receptor agonists and uses thereof (2021-03-30),

5. 10927082 - Farnesoid X receptor agonists and uses thereof (2021-02-23),

6. 10703712 - Farnesoid X receptor agonists and uses thereof (2020-07-07),

7. 10626081 - Farnesoid X receptor agonists and uses thereof (2020-04-21),

8. 10377717 - Farnesoid X receptor agonists and uses thereof (2019-08-13),

Metacrine is a biotechnology company focused on discovering and developing innovative therapies for metabolic diseases. The company's proprietary drug discovery platform enables the identification of novel drug targets and the development of small molecule drugs to address unmet medical needs in metabolic diseases such as NASH and diabetes. Metacrine is committed to bringing new treatment options to patients with metabolic diseases.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 2 2025

8 Patents

#608 in San Diego, CA

#8,276 in California

#34,838 in US

San Diego, CA, United States of America

Metacrine, Inc.